These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 6972418)

  • 21. Heterogeneity of group A streptococcal pyrogenic exotoxin type B.
    Barsumian EL; Cunningham CM; Schlievert PM; Watson DW
    Infect Immun; 1978 May; 20(2):512-8. PubMed ID: 352946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.
    Schlievert PM
    Infect Immun; 1982 Apr; 36(1):123-8. PubMed ID: 7042568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production.
    Schlievert PM; Blomster DA; Kelly JA
    Obstet Gynecol; 1984 Nov; 64(5):666-71. PubMed ID: 6436761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of toxic shock syndrome Staphylococcus aureus, endotoxin and tampons in a mouse model.
    Tierno PM; Malloy V; Matias JR; Hanna BA
    Clin Invest Med; 1987 Mar; 10(2):64-70. PubMed ID: 3581548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study on the pathogenesis of Streptococcus mitis exotoxin].
    Lu H; Weng X; Yin Y; Chen Y; Jiang X; Wang H; Qian K; Zhu B; Peng B; Gong Z
    Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):29-31. PubMed ID: 11798555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superantigenic exotoxin production by isolates of Staphylococcus aureus from the Kawasaki syndrome patients and age-matched control children.
    Todome Y; Ohkuni H; Mizuse M; Okibayashi F; Ohtani N; Suzuki H; Song C; Igarashi H; Harada K; Sakurai S
    J Med Microbiol; 1995 Feb; 42(2):91-5. PubMed ID: 7869353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the hemolytic activity of Staphylococcus aureus strains associated with toxic shock syndrome.
    Chow AW; Gribble MJ; Bartlett KH
    J Clin Microbiol; 1983 Mar; 17(3):524-8. PubMed ID: 6841587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological properties of toxic shock syndrome exotoxin.
    Schlievert PM
    Surv Synth Pathol Res; 1984; 3(1):54-62. PubMed ID: 6505480
    [No Abstract]   [Full Text] [Related]  

  • 29. Gram-negative endotoxins and staphylococcal toxic shock syndrome.
    de Azavedo JC; Hartigan PJ; de Saxe M; Arbuthnott JP
    Prog Clin Biol Res; 1985; 189():419-32. PubMed ID: 4048216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.
    Murray DL; Prasad GS; Earhart CA; Leonard BA; Kreiswirth BN; Novick RP; Ohlendorf DH; Schlievert PM
    J Immunol; 1994 Jan; 152(1):87-95. PubMed ID: 8254210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the staphylococcal causation of toxic shock syndrome.
    Altemeier WA; Lewis S; Schlievert PM; Bjornson HS
    Surg Gynecol Obstet; 1981 Oct; 153(4):481-5. PubMed ID: 6456561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A rapid method of detecting the staphylococcal exotoxin of toxic shock].
    Fluer FS; Pozhar PF; Ratgauz GL; Akatov AK
    Lab Delo; 1989; (4):62-4. PubMed ID: 2470975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic sinusitis with nasal polyps: staphylococcal exotoxin immunoglobulin E and cellular inflammation.
    Conley DB; Tripathi A; Ditto AM; Reid K; Grammer LC; Kern RC
    Am J Rhinol; 2004; 18(5):273-8. PubMed ID: 15586797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
    Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
    JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.
    Parsonnet J; Gillis ZA; Pier GB
    J Infect Dis; 1986 Jul; 154(1):55-63. PubMed ID: 3486924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus.
    Lee PK; Kreiswirth BN; Deringer JR; Projan SJ; Eisner W; Smith BL; Carlson E; Novick RP; Schlievert PM
    J Infect Dis; 1992 Jun; 165(6):1056-63. PubMed ID: 1583323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic studies on Staphylococcal strains from patients with toxic shock syndrome.
    Kreiswirth BN; Novick RP; Schlievert PM; Bergdoll M
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):974-7. PubMed ID: 6212007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome.
    Ikejima T; Dinarello CA; Gill DM; Wolff SM
    J Clin Invest; 1984 May; 73(5):1312-20. PubMed ID: 6609169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins.
    Schlievert PM
    J Am Coll Surg; 1996 Jul; 183(1):19-24. PubMed ID: 8673303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypic characterization of toxic shock syndrome toxin-1-producing strains of Staphylococcus aureus isolated in the Czech Republic.
    Hrstka R; Růzicková V; Petrás P; Pantůcek R; Rosypal S; Doskar J
    Int J Med Microbiol; 2006 Feb; 296(1):49-54. PubMed ID: 16423687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.